Physician profile
Michael D Hermann
NPI 1245673268
$7,381.35
in general payments reported to CMS, 2019-2025
27 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,764 · 2020: $2,573 · 2021: $1,172 · 2022: $14.06 · 2023: $1,447 · 2024: $204 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976 · Travel and Lodging: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $975.86 |
| Travel and Lodging | $883.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $2,488.19 | 2019-2021 | |
| Relievant Medsystems, INC. | $1,381.68 | 2021-2023 | Intracept |
| Vertos Medical, INC. | $1,250.34 | 2019-2021 | |
| Medtronic, INC. | $519.86 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Abbott Laboratories | $451.84 | 2019-2022 | |
| Boston Scientific Corporation | $423.79 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $129.07 | 2020-2021 | |
| Abbvie INC. | $121.76 | 2021-2025 | |
| Stimwave Technologies Incorporated | $96.86 | 2020 | |
| Medtronic USA, INC. | $92.37 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $55.67 | 2019-2021 | |
| Almatica Pharma LLC | $52.31 | 2021 | |
| Redhill Biopharma INC. | $47.77 | 2020-2021 | |
| Daiichi Sankyo INC. | $36.63 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.69 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $27.82 | 2019-2020 | |
| Assertio Therapeutics, INC. | $26.92 | 2019 | |
| Pacira Therapeutics, INC. | $26.50 | 2019 | |
| Pfizer INC. | $25.50 | 2019-2021 | |
| Spr Therapeutics, INC | $17.88 | 2024 | Sprint Pns System |
| Allergan, INC. | $15.69 | 2019 | |
| Nalu Medical, INC. | $15.60 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.77 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.82 | 2019 | |
| Shionogi INC | $10.91 | 2019 | |
| Saluda Medical Americas, INC. | $10.02 | 2024 | Evoke |
| Epimed International, INC | $2.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.